Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Cochat

Showing results (161-170 of 225) with videos related to

Pageof 23
Sort By:
Pediatric Nephrology (Berlin, Germany)|November 21, 2022
Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: a retrospective studyMajid Alfadhel, Muhammad Umair, Malak A Alghamdi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safetyCraig B Langman, Larry A Greenbaum, Minnie Sarwal, et al.
Therapie|April 7, 2020
Ségolène Gaillard, Laurent Roche, Georges Deschênes, et al.
Pediatric Nephrology (Berlin, Germany)|May 15, 2015
Renal function can be impaired in children with primary hyperoxaluria type 3Lise Allard, Pierre Cochat, Anne-Laure Leclerc, et al.
Transplantation|October 24, 2002
A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluationsJohn M Kovarik, Gisela Offner, Michel Broyer, et al.
Kidney International|September 5, 2021
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluriaBernd Hoppe, Annelize Koch, Pierre Cochat, et al.
Transplantation|July 25, 2006
Body growth after combined liver-kidney transplantation in children with primary hyperoxaluria type 1Richard Nissel, Kay Latta, Marie-France Gagnadoux, et al.
Pediatric Nephrology (Berlin, Germany)|March 13, 2009
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter studyDjalila Mekahli, Aurelia Liutkus, Bruno Ranchin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2017
Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney DiseaseStéphanie De Rechter, Justine Bacchetta, Nathalie Godefroid, et al.
Kidney International|February 7, 2014
Survival and clinical outcomes of children starting renal replacement therapy in the neonatal periodKariljn J van Stralen, Dagmara Borzych-Dużalka, Hiroshi Hataya, et al.
Pageof 23

Showing results (161-170 of 225) with videos related to

Sort By:
Pageof 23
Pediatric Nephrology (Berlin, Germany)|November 21, 2022
Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: a retrospective studyMajid Alfadhel, Muhammad Umair, Malak A Alghamdi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safetyCraig B Langman, Larry A Greenbaum, Minnie Sarwal, et al.
Therapie|April 7, 2020
Ségolène Gaillard, Laurent Roche, Georges Deschênes, et al.
Pediatric Nephrology (Berlin, Germany)|May 15, 2015
Renal function can be impaired in children with primary hyperoxaluria type 3Lise Allard, Pierre Cochat, Anne-Laure Leclerc, et al.
Transplantation|October 24, 2002
A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluationsJohn M Kovarik, Gisela Offner, Michel Broyer, et al.
Kidney International|September 5, 2021
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluriaBernd Hoppe, Annelize Koch, Pierre Cochat, et al.
Transplantation|July 25, 2006
Body growth after combined liver-kidney transplantation in children with primary hyperoxaluria type 1Richard Nissel, Kay Latta, Marie-France Gagnadoux, et al.
Pediatric Nephrology (Berlin, Germany)|March 13, 2009
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter studyDjalila Mekahli, Aurelia Liutkus, Bruno Ranchin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2017
Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney DiseaseStéphanie De Rechter, Justine Bacchetta, Nathalie Godefroid, et al.
Kidney International|February 7, 2014
Survival and clinical outcomes of children starting renal replacement therapy in the neonatal periodKariljn J van Stralen, Dagmara Borzych-Dużalka, Hiroshi Hataya, et al.
Pageof 23